Cardiol Therapeutics (CRDL) P/E (2019 - 2026)
Cardiol Therapeutics (CRDL) P/E from Jan 15, 2019 to Jun 15, 2026. The TTM Cardiol Therapeutics (CRDL) P/E is -3.71. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cardiol Therapeutics (CRDL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.71 | +9.39% |
| 2025 | -3.40 | -8.87% |
| 2024 | -3.73 | +6.41% |
| 2023 | -3.50 | +100.08% |
| 2022 | -1.75 | -52.05% |
| 2021 | -3.65 | -35.71% |
| 2020 | -5.68 | -38.75% |
| 2019 | -9.27 | N/A |
Comparison Cardiol Therapeutics (CRDL) P/E with competitors
Cardiol Therapeutics (CRDL) P/E is -3.71.